Cadmium causes hyperglycemia, activation of hepatic and renal gluconeogenic enzymes such as glucose-6-phosphatase and fructose-1,6-diphosphatase, increases hepatic and renal zinc, renal copper and decreases hepatic and renal iron levels in rats. Glibenclamide, a hypoglycemic agent, significantly reversed most of the Cd effects, enhanced fecal excretion of Cd and potentiated urinary and fecal elimination of Cd by calcium trisodium diethylenetriaminepentaacetate (CaNa3DTPA), a commonly used metal chelator. However, the restoration of Cd-induced alterations in carbohydrate metabolism was not related to elimination of Cd from the tissues.
Cantilena, L.R., Jr. and Klaasen, C.D. (1981). Comparison of the effectiveness of several chelators after single administration on the toxicity, excretion and distribution of cadmium. Toxicol. Appl. Pharmacol. 58:452-460.
2.
Chapatwala, K.D., Rajanna, B. and Desaiah, D. (1980). Cadmium-induced changes in gluconeogenic enzymes in rat kidney and liver. Drug Chem. Toxicol. 3:407-420.
3.
Failla, M.L. and Kiser, R.A. (1981). Altered tissue content and cytosol distribution of trace metals in experimental diabetes. J. Nutr. 111:1900-1909.
4.
Failla, M.L. and Kiser, R.A. (1983). Hepatic and renal metabolism of copper and zinc in the diabetic rat. Am. J. Physiol.244:(Endocrinol. Metab.7), E115-E121.
5.
Fiske, C.H. and Subbarow, Y. (1957). Methods for estimation of phosphate. In: Methods in Enzymology (S.P. Colowick and N.O. Kaplan, eds.), Vol. III, pp. 843-844. Academic Press, New York.
6.
Folin, O. and Wu, H. (1965). Determination of glucose. In: Hawk's Physiological Chemistry (B.L. Oser , ed.), 14th Ed, pp. 1052-1053. McGraw Hill, New York.
7.
Grandjean, P. (1979). Occupational lead exposure in Denmark: Screening with the hematofluorometer. Brit. J. Ind. Med. 36:52-58.
8.
Havu, N. (1969). Sulfhydryl inhibitors and pancreatic islet tissue . Acta Endocrinol. Suppl. 139:1-231.
9.
Ithakissios, D.S., Kessler, W.V., Arvesen, J.N. and Born, G.S. (1974). Differences in uptake of cadmium in selected organs of normal and alloxan-diabetic rats. Toxicol. Appl. Pharmacol . 28:235-239.
10.
Lowry, O.H., Rosebrough, N.J., Farr, A.L. and Randal, R.J. (1951). Protein measurement with folin-phenol reagent . J. Biol. Chem. 193:265-275.
11.
Mcgilvery, R.W. (1955). Fructose-1,6-diphosphatase from the liver. In: Methods in Enzymology (S.P. Colowick and N.O. Kaplan, eds), Vol. II, pp. 543-544. Academic Press, New York.
12.
Nordberg, M. (1978). Studies on metallothionein and cadmium. Environ. Res. 15:381-404.
13.
Parker, M.M., Humoller, F.L. and Mahler, D.J. (1967). Determination of copper and zinc in biological material. Clin. Chem. 13:40-48.
14.
Planas-Bohne, F. and Lehmann, M. (1983). Influence of chelating agents on the distribution and excretion of cadmium in rats. Toxicol. Appl. Pharmacol . 67:408-416.
15.
Shaikh, Z.A. and Smith, J-C. (1980). Metabolism of orally ingested cadmium in humans . In: Mechanisms of Toxicity and Hazard Evaluation (B. Holmstedt, R. Lauwerys, M. Mercier and M. Roberfroid, eds.), pp. 569-574, Elsevier, New York.
16.
Stonard, M.D. and Webb, M. (1976). Influence of dietary cadmium on the distribution of the essential metals copper, zinc and iron in the tissues of the rats. Chem. Biol. Interact. 15:349-363.
17.
Swanson, M.A. (1955). Glucose-6-phosphatase from liver. In: Methods in Enzymology (S.P. Colowick and N.O. Kaplan, eds.), Vol. II, pp. 541-543, Academic Press, New York.
18.
Tewari, P.C., Jain, V.K., Ashquin, M. and Tandon, S.K. (1986). Influence of protein deficiency on cadmium toxicity in rats. Arch. Environ. Contam. Toxicol. 15:409-415.
19.
Waalkes, M.P., Watkins, J.B. and Klaassen, C.D. (1983). Minimal role of metallothionein in decreased chelator efficacy for cadmium. Toxicol. Appl. Pharmacol. 68:392-398.
